Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
3.860
-0.170 (-4.22%)
Jul 1, 2025, 11:08 AM - Market open
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,738,023
Market Cap
2.10M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
BBLG News
- 19 hours ago - Bone Biologics Announces Closing of $5.0 Million Public Offering - Business Wire
- 4 days ago - Why Is Bone Biologics Stock Surging On Friday? - Benzinga
- 4 days ago - Bone Biologics Announces Pricing of $5.0 Million Public Offering - Business Wire
- 4 days ago - Bone Biologics Files Patent Application for Bone Regeneration Technology - Business Wire
- 4 days ago - Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements - Business Wire
- 25 days ago - Bone Biologics Announces 1-for-6 Reverse Stock Split - Business Wire
- 9 months ago - Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - Business Wire
- 10 months ago - Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire